Holen Sie sich die Stockscreener-App
4.32
4.60%
0.19
Handel nachbörslich:
4.35
0.03
+0.69%
Schlusskurs vom Vortag:
$4.13
Offen:
$4.09
24-Stunden-Volumen:
16,495
Relative Volume:
0.31
Marktkapitalisierung:
$16.48M
Einnahmen:
Nettoeinkommen (Verlust:
$1.52M
KGV:
-0.6834
EPS:
-6.3213
Netto-Cashflow:
$-1.14M
1W Leistung:
-15.62%
1M Leistung:
-28.83%
6M Leistung:
+50.00%
1J Leistung:
-80.47%
1-Tages-Spanne:
$4.09
$4.44
1-Wochen-Bereich:
$4.09
$5.205
52-Wochen-Spanne:
$1.92
$22.96
Psyence Biomedical Ltd Stock (PBM) Company Profile
Firmenname
Psyence Biomedical Ltd
Sektor
Branche
Telefon
-
Adresse
-
Compare PBM vs VRTX, MRNA, REGN, ARGX, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PBM
Psyence Biomedical Ltd
|
4.32 | 16.48M | 0 | 1.52M | -1.14M | -6.3213 |
VRTX
Vertex Pharmaceuticals Inc
|
508.75 | 128.95B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
236.50 | 94.42B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
796.34 | 81.99B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
846.27 | 53.22B | 4.16B | 1.29B | 734.26M | 19.58 |
ONC
Beone Medicines Ltd Adr
|
374.08 | 42.32B | 5.76B | 514.49M | 1.10B | 4.4813 |
Psyence Biomedical Ltd Aktie (PBM) Neueste Nachrichten
POM Stock Price, Quote & News - Syfe
A passive holder reports more than 5% of Psyence Biomedical (PBM) common shares. - stocktitan.net
Psyence Biomedical Warrant (PBMWW) Slides Nearly 20% to $0.02 as Sub-Penny Range TightensWave Alternation - https://www.dars.gov.et/
Psyence BioMed Agrees Up to $5 Million PsyLabs Investment and Forms Texas Ibogaine Unit - Yahoo Finance
Psyence BioMed invests up to $5M in PsyLabs, plans ibogaine trial By Investing.com - Investing.com Canada
Two companies agree to trade ownership stakes worth about $9 million apiece - Stock Titan
[6-K] PSYENCE BIOMEDICAL LTD. Current Report (Foreign Issuer) | PBM SEC FilingForm 6-K - Stock Titan
Psyence BioMed Announces Strategic Ibogaine Investment - GlobeNewswire
Psyence BioMed invests up to $5M in PsyLabs, plans ibogaine trial By Investing.com - Investing.com
SXTC Stock Price, Quote & News - Syfe
PSYENCE BIOMEDICAL LTD. SEC Filing (Sep 2, 2026) - Stock Titan
OPTH Stock Price, Quote & News - Syfe
Psyence BioMed (Nasdaq: PBM) holders may resell 1.15M shares - Stock Titan
Psyence Biomedical Ltd. Common Shares (NASDAQ: PBM) Stock Price, News & Analysis - kalkine.ca
Psyence Biomedical Ltd. Common Shares (NASDAQ: PBM) Stock Price, News & Analysis - Kalkine
Psyence BioMed Welcomes U.S. Administration's Latest Action to Accelerate Ibogaine Development - marketscreener.com
Psyence BioMed responds to Trump ibogaine announcement By Investing.com - Investing.com Canada
Psyence BioMed responds to Trump ibogaine announcement By Investing.com - Investing.com Nigeria
Psyence Biomedical stock surges on Trump ibogaine announcement By Investing.com - Investing.com Australia
Psyence (PBM) Session Recap: Closes 23.82% Higher at $4.47; Range and Risk: $4.25 and $4.69 Define the Nearby Reference Levels in the Latest ReadingSeasonality Effect - vinanet.vn
Psyence BioMed responds to Trump ibogaine announcement By Investing.com - Investing.com India
Psyence BioMed Welcomes White House Support for Accelerated U.S. Ibogaine Development - Quiver Quantitative
Psyence BioMed Welcomes U.S. Administration’s Latest Action to Accelerate Ibogaine Development - Yahoo Finance Singapore
Psyence Biomedical stock surges on Trump ibogaine announcement By Investing.com - Investing.com India
Psyence Biomedical stock surges on Trump ibogaine announcement By Investing.com - Investing.com Nigeria
Psyence Biomedical stock surges on Trump ibogaine announcement By Investing.com - Investing.com South Africa
Psyence Biomedical stock surges on Trump ibogaine announcement - Investing.com
Ibogaine could rise as potential psychedlic treatment with Trump announcement - Seeking Alpha
Psyence (PBM) Session Recap: Closes 23.82% Higher at $4.47; Range and Risk: $4.25 and $4.69 Define the Nearby Reference Levels in the Latest ReadingEarnings Breakout Stocks - dars.gov.et
Psyence Biomedical (PBM) Slips 2.25% to $3.48: Testing Support as Resistance HoldsLong Setup Ideas - vinanet.vn
Psyence Biomedical (PBM) Slips 2.25% to $3.48: Testing Support as Resistance HoldsPrice Surge Stocks - dars.gov.et
Psyence Biomedical (PBM) Slips 2.27% as Shares Test Key $3.40 LevelFactor Valuation - dars.gov.et
Psyence Biomedical (PBM) Slips 2.27% as Shares Test Key $3.40 LevelAAII Bullish - vinanet.vn
Psyence Biomedical Ltd (PBM) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Psyence Biomedical Ltd. Revenue Breakdown – NASDAQ:PBMWW - tradingview.com
Psyence Biomedical Details NPX-5 Trial Progress and Integrated Psychedelic Platform in August Investor Update - TipRanks
Psyence BioMed (Nasdaq: PBM) outlines psilocybin and ibogaine clinical plans - Stock Titan
Psyence Biomedical Warrant (PBMWW) Jumps 9.47% to $0.03 as Psychedelic Biotech Speculation IntensifiesBlock Trade Flow - vinanet.vn
Psyence Biomedical Warrant (PBMWW) Jumps 9.47% to $0.03 as Psychedelic Biotech Speculation IntensifiesFast Moving Stocks - www.dars.gov.et
Psyence Biomedical Warrant (PBMWW) Jumps 9.47% to $0.03 as Psychedelic Biotech Speculation IntensifiesSell Signal Alerts - www.dars.gov.et
Price to book forward of Psyence Biomedical Ltd. – NASDAQ:PBM - TradingView
Price to sales forward of Psyence Biomedical Ltd. – NASDAQ:PBM - TradingView
Enterprise value to EBITDA forward of Psyence Biomedical Ltd. – NASDAQ:PBM - TradingView
Psyence Biomedical (PBM) Falls 5.65% to $3.17 as Micro-Cap Biotech Faces Renewed Selling PressureMACD Signal Stocks - vinanet.vn
Psyence Biomedical Ltd (PBM) Valuation: PE, PB & Fair Value Analysis - TradingKey
Psyence Biomedical Ltd (PBM) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Psyence Biomedical Warrants (PBMWW) Surge 48%: A Closer Look at the Speculative MovePCR Spike - dars.gov.et
Psyence Biomedical Ltd (PBM) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Psyence Biomedical Ltd (PBM) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
PBM|Psyence Biomedical Ltd|Price:2.950|Chg%:+0.130 - TradingKey
Finanzdaten der Psyence Biomedical Ltd-Aktie (PBM)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):